OncoArendi Therapeutics
2012
FOUNDED
PUBLIC
STATUS
81-90
EMPLOYEES
OAT
STOCK SYMBOL
$3.30
SHARE PRICE
(As of Wednesday Closing)
Description
Oncoarendi Therapeutics SA is a biopharmaceutical company engaged in discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
WAR
Primary Office
- Żwirki i Wigury 101
- Warszawa, 02-089
- Poland
+48 22 000 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore OncoArendi Therapeutics’s full profile, request a free trial.
OncoArendi Therapeutics Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $2.42 - $5.49 | $45.1M | $3.15 | -$0.09 | 8.83K | 13.7M |
OncoArendi Therapeutics Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 29,859 | 36,360 | ||
| Revenue | 1 | 1 | 2 | 2 |
| EBITDA | (1,373) | (1,406) | (671) | (604) |
| Net Income | (1,228) | (1,231) | (636) | (614) |
| Total Assets | 21,248 | 22,857 | 9,930 | 3,705 |
| Total Debt | 627 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
OncoArendi Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore OncoArendi Therapeutics‘s full profile, request access.
Request full access to PitchBookOncoArendi Therapeutics Executive Team (3)
OncoArendi Therapeutics Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Sławomir Broniarek | OncoArendi Therapeutics | Chief Financial Officer & Board Member | 000 0000 | |
| Stanisław Pikul Ph.D | OncoArendi Therapeutics | Co-Founder, Vice President, Development & Board Member | 000 0000 |